These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Correlation between measles-neutralizing antibody and HI antibody, between measles-neutralizing antibody and PA antibody among pregnant women, and protective levels of three titration types]. Takayama N; Shoda A; Okazaki T; Ichinohe S; Saika S; Inaba N Kansenshogaku Zasshi; 2007 Nov; 81(6):675-80. PubMed ID: 18095465 [TBL] [Abstract][Full Text] [Related]
23. ELISA underestimates measles antibody seroprevalence in US military recruits. Mancuso JD; Krauss MR; Audet S; Beeler JA Vaccine; 2008 Sep; 26(38):4877-8. PubMed ID: 18586062 [TBL] [Abstract][Full Text] [Related]
24. Measles immunization strategy: measles antibody response following MMR II vaccination of children at one year of age. Ratnam S; West R; Gadag V; Burris J Can J Public Health; 1996; 87(2):97-100. PubMed ID: 8753636 [TBL] [Abstract][Full Text] [Related]
25. Measles immunity and response to revaccination of a young adult population in Israel. Mendelson E; Duvdevani P; Varsano N; Lerman Y; Slepon R; Dagan R; Cohen D; Danon Y; Shohat T J Med Virol; 1996 Nov; 50(3):249-53. PubMed ID: 8923290 [TBL] [Abstract][Full Text] [Related]
26. An evaluation of nine commercial EIA kits for the detection of measles specific IgG. Hesketh L; Charlett A; Farrington P; Miller E; Forsey T; Morgan-Capner P J Virol Methods; 1997 Jun; 66(1):51-9. PubMed ID: 9220390 [TBL] [Abstract][Full Text] [Related]
27. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era. Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581 [TBL] [Abstract][Full Text] [Related]
28. Enzyme-linked immunosorbent assay (ELISA) for measles antibody. A comparison with haemagglutination inhibition, immunofluorescence and plaque neutralization tests. de Souza VA; Pannuti CS; Sumita LM; Albrecht P Rev Inst Med Trop Sao Paulo; 1991; 33(1):32-6. PubMed ID: 1843394 [TBL] [Abstract][Full Text] [Related]
29. Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity. Haralambieva IH; Ovsyannikova IG; Vierkant RA; Poland GA Clin Vaccine Immunol; 2008 Jul; 15(7):1054-9. PubMed ID: 18463223 [TBL] [Abstract][Full Text] [Related]
30. Neutralization enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. Nates SV; Rey GY; Giordano MO; Depetris AR; Boshell J Viral Immunol; 1995; 8(1):47-52. PubMed ID: 8546804 [TBL] [Abstract][Full Text] [Related]
31. Measles Antibodies in Mother-Infant Dyads in Tianjin, China. Boulton ML; Wang X; Wagner AL; Zhang Y; Carlson BF; Gillespie BW; Ding Y J Infect Dis; 2017 Nov; 216(9):1122-1129. PubMed ID: 28968908 [TBL] [Abstract][Full Text] [Related]
32. Measles virus-specific IgG4 antibody titer as a serologic marker of post-vaccinal immune response. Isa MB; MartÃnez LC; Ferreyra LJ; Giordano MO; Barril PA; Massachessi G; Nates SV Viral Immunol; 2006; 19(2):335-9. PubMed ID: 16817776 [TBL] [Abstract][Full Text] [Related]
33. Development of a new neutralization test for measles virus. Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. Sha BE; Harris AA; Benson CA; Atkinson WL; Urbanski PA; Stewart JA; Williams WW; Murphy RL; Phair JP; Levin SA J Infect Dis; 1991 Nov; 164(5):973-5. PubMed ID: 1682395 [TBL] [Abstract][Full Text] [Related]
35. Nonclassic measles infections in an immune population exposed to measles during a college bus trip. Helfand RF; Kim DK; Gary HE; Edwards GL; Bisson GP; Papania MJ; Heath JL; Schaff DL; Bellini WJ; Redd SC; Anderson LJ J Med Virol; 1998 Dec; 56(4):337-41. PubMed ID: 9829639 [TBL] [Abstract][Full Text] [Related]
38. [A study on measles immune status by ELISA]. Li GQ Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Apr; 10(2):105-8. PubMed ID: 2736614 [TBL] [Abstract][Full Text] [Related]
39. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment. LeBaron CW; Beeler J; Sullivan BJ; Forghani B; Bi D; Beck C; Audet S; Gargiullo P Arch Pediatr Adolesc Med; 2007 Mar; 161(3):294-301. PubMed ID: 17339511 [TBL] [Abstract][Full Text] [Related]
40. Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays. Mauldin J; Carbone K; Hsu H; Yolken R; Rubin S J Clin Microbiol; 2005 Sep; 43(9):4847-51. PubMed ID: 16145156 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]